Vebreltinib is an oral small-molecule tyrosine kinase inhibitor, primarily used for the treatment of patients with advanced or metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutation.
What is Vebreltinib?
Update: 04 Feb,2026 Source: Haiou Health Views: 101
